BioCentury
ARTICLE | Company News

Amersham Pharmacia Biotech Ltd., Analytica of Branford Inc., Beckman Coulter, The SNP Consortium deal

March 20, 2000 8:00 AM UTC

Amersham, a division of Nycomed Amersham plc (LSE:NAM; OSE:NYA; NYE, Little Chalfont, U.K.) and Analytica will develop mass spectrometry systems to characterize proteins and peptides. Amersham will exclusively distribute and manufacture the systems, and intends to acquire a majority stake in Analytica.

Separately, Amersham and BEC will develop capillary coatings and matrices for DNA sequencing and fragment analysis using BEC's capillary electrophoresis technology. The technology is used in BEC's CEQ 2000 eight capillary DNA analysis system and Amersham's MegaBACE 1000 96-capillary DNA sequencer. ...